27602107|t|Distinctive pattern of let-7 family microRNAs in aggressive carcinoma of the oral tongue in young patients
27602107|a|Oral cavity squamous cell carcinoma may be more aggressive at presentation and recurrence in young patients compared with older patients. Dysregulation of microRNAs (miRNAs or miRs) has been associated with the development and prognosis of oral cavity cancer. The present study investigated miRNA expression in carcinoma of the oral tongue in young patients. miRNA expression profiles were evaluated in formalin-fixed, paraffin-embedded samples of tumor and normal mucosa from 12 patients aged <30 years old with squamous cell carcinoma of the tongue. The levels of let-7f-5p, miR-30b-5p and let-7e-5p were upregulated in tumors (P<0.05). The expression of let-7f-5p was upregulated in non-aggressive tumors, while the expression of let-7e-5p was upregulated in aggressive tumors, compared with the corresponding normal tissue. Aggressive tumors had higher levels of let-7c, miR-130a-3p, miR-361-5p, miR-99a-5p, miR-29c-3p and let-7d-5p than non-aggressive tumors (P<0.05). The findings remained significant for let-7c upon false-discovery rate correction. An excellent correlation was noticed on validation of NanoString counts by quantitative polymerase chain reaction. The comparison with published findings in adults demonstrated a unique miRNA signature in young patients with aggressive disease. Aggressive oral cavity cancer in patients <30 years old is associated with a distinctive expression pattern of the let-7 family. Larger studies including direct comparison with older patients are warranted.
27602107	0	11	Distinctive	T080	C1521970
27602107	12	19	pattern	T082	C0449774
27602107	23	28	let-7	T086	C1708690
27602107	29	35	family	T077	C1704727
27602107	36	45	microRNAs	T114,T123	C1101610
27602107	49	69	aggressive carcinoma	T191	C2945759
27602107	77	88	oral tongue	T023	C0040408
27602107	92	97	young	T079	C0332239
27602107	98	106	patients	T101	C0030705
27602107	107	142	Oral cavity squamous cell carcinoma	T191	C0585362
27602107	155	165	aggressive	T033	C0243095
27602107	169	181	presentation	T078	C0449450
27602107	186	196	recurrence	T046	C2825055
27602107	200	205	young	T079	C0332239
27602107	206	214	patients	T101	C0030705
27602107	215	223	compared	T052	C1707455
27602107	229	234	older	T098	C0001792
27602107	235	243	patients	T101	C0030705
27602107	245	258	Dysregulation	T169	C0205245
27602107	262	271	microRNAs	T114,T123	C1101610
27602107	273	279	miRNAs	T114,T123	C1101610
27602107	283	287	miRs	T114,T123	C1101610
27602107	298	313	associated with	T080	C0332281
27602107	318	329	development	T040	C0678723
27602107	334	343	prognosis	T058	C0033325
27602107	347	365	oral cavity cancer	T191	C0151546
27602107	379	384	study	T062	C2603343
27602107	385	397	investigated	T169	C1292732
27602107	398	414	miRNA expression	T045	C0017262
27602107	418	446	carcinoma of the oral tongue	T191	C0558353
27602107	450	455	young	T079	C0332239
27602107	456	464	patients	T101	C0030705
27602107	466	471	miRNA	T114,T123	C1101610
27602107	472	491	expression profiles	T081	C1956267
27602107	497	506	evaluated	T058	C0220825
27602107	510	551	formalin-fixed, paraffin-embedded samples	T024	C2711483
27602107	555	560	tumor	T191	C0027651
27602107	572	578	mucosa	T024	C0026724
27602107	587	595	patients	T101	C0030705
27602107	611	614	old	T079	C0580836
27602107	620	657	squamous cell carcinoma of the tongue	T191	C0349566
27602107	663	669	levels	T080	C0441889
27602107	673	682	let-7f-5p	T114	C2976082
27602107	684	694	miR-30b-5p	T114	C2741800
27602107	699	708	let-7e-5p	T114	C2605091
27602107	714	725	upregulated	T044	C0041904
27602107	729	735	tumors	T191	C0027651
27602107	750	760	expression	T045	C0017262
27602107	764	773	let-7f-5p	T114	C2976082
27602107	778	789	upregulated	T044	C0041904
27602107	793	807	non-aggressive	T033	C0243095
27602107	808	814	tumors	T191	C0027651
27602107	826	836	expression	T045	C0017262
27602107	840	849	let-7e-5p	T114	C2605091
27602107	854	865	upregulated	T044	C0041904
27602107	869	886	aggressive tumors	T191	C2945759
27602107	888	896	compared	T052	C1707455
27602107	927	933	tissue	T024	C0040300
27602107	935	952	Aggressive tumors	T191	C2945759
27602107	957	963	higher	T080	C0205250
27602107	964	970	levels	T080	C0441889
27602107	974	980	let-7c	T114	C2605089
27602107	982	993	miR-130a-3p	T114	C2973798
27602107	995	1005	miR-361-5p	T114,T123	C3496137
27602107	1007	1017	miR-99a-5p	T114,T123	C3253324
27602107	1019	1029	miR-29c-3p	T114,T123	C2354351
27602107	1034	1043	let-7d-5p	T114	C2605097
27602107	1049	1063	non-aggressive	T033	C0243095
27602107	1064	1070	tumors	T191	C0027651
27602107	1085	1093	findings	T033	C0243095
27602107	1103	1114	significant	T078	C0750502
27602107	1119	1125	let-7c	T114	C2605089
27602107	1131	1151	false-discovery rate	T081	C1880720
27602107	1152	1162	correction	T169	C1947976
27602107	1167	1176	excellent	T080	C1961136
27602107	1177	1188	correlation	T080	C1707520
27602107	1204	1214	validation	T062	C1519941
27602107	1218	1235	NanoString counts	T081	C0392762
27602107	1239	1277	quantitative polymerase chain reaction	T059	C2733022
27602107	1283	1293	comparison	T052	C1707455
27602107	1299	1308	published	T170	C1704324
27602107	1309	1317	findings	T033	C0243095
27602107	1321	1327	adults	T100	C0001675
27602107	1343	1349	unique	T080	C1710548
27602107	1350	1355	miRNA	T114,T123	C1101610
27602107	1356	1365	signature	T169	C1708225
27602107	1369	1374	young	T079	C0332239
27602107	1375	1383	patients	T101	C0030705
27602107	1389	1407	aggressive disease	T191	C2945759
27602107	1409	1419	Aggressive	T033	C0243095
27602107	1420	1438	oral cavity cancer	T191	C0151546
27602107	1442	1450	patients	T101	C0030705
27602107	1461	1464	old	T079	C0580836
27602107	1468	1483	associated with	T080	C0332281
27602107	1486	1497	distinctive	T080	C1521970
27602107	1498	1508	expression	T045	C0017262
27602107	1509	1516	pattern	T082	C0449774
27602107	1524	1529	let-7	T086	C1708690
27602107	1530	1536	family	T077	C1704727
27602107	1538	1544	Larger	T081	C0549177
27602107	1545	1552	studies	T062	C2603343
27602107	1553	1562	including	T169	C0332257
27602107	1563	1569	direct	T080	C1947931
27602107	1570	1580	comparison	T052	C1707455
27602107	1586	1591	older	T098	C0001792
27602107	1592	1600	patients	T101	C0030705
27602107	1605	1614	warranted	T033	C0243095